Oppenheimer Remains a Buy on Hms Holdings Corp (HMSY)


In a report released today, Mohan Naidu from Oppenheimer reiterated a Buy rating on Hms Holdings Corp (HMSY), with a price target of $41. The company’s shares opened today at $33.

Naidu noted:

“HMSY reported revenue of $156M, in line with estimates, but adj. EPS beat estimates at $0.31 (excluding tax benefit). The company saw continued strength in PI and total population health solutions with both of the segments growing strongly. The recent investments in technology and population health solution expansions are starting to deliver results and underscores our thesis on the stock. While the limited lift in EBITDA margins into 2019 could pause investors, we believe the margin expansion will come as the technology investments pay off in lowering the cost of the services provided. Meanwhile, the traction in new services, and the opportunities to monetize the company’s strong dataset using Machine Learning intrigues us. Increasing our target to $41 from $37. Reiterate Outperform rating.”

According to TipRanks.com, Naidu is a 5-star analyst with an average return of 10.8% and a 54.1% success rate. Naidu covers the Services sector, focusing on stocks such as Tivity Health Inc, Evolent Health, and Premier Inc.

Hms Holdings Corp has an analyst consensus of Hold.

See today’s analyst top recommended stocks >>

Hms Holdings Corp’s market cap is currently $2.62B and has a P/E ratio of 56.99. The company has a Price to Book ratio of 4.02.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

HMS Holdings Corp. engages in the provision of cost containment solutions in the healthcare marketplace. The firm operates through its wholly owned subsidiaries, Health Management Systems, Inc. HealthDataInsights, Inc., HMS Care Analytics, Inc., IntegriGuard, LLC, and Reimbursement Services Group Inc..

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts